Some of our previous findings have shown impairment of the placenta due to the presence of cancer or some tumour factors, such as proinflammatory cytokines interleukin-6 (IL-6), interferon-gamma (IFN-γ), and tumour-necrosis factor (TNFα) [24]. The gene discussed is IFNG; the disease is cancer.